Specifically, the majority (8 out of 9) of studies investigating P2X7 channels in preclinical models for epilepsy, ischemia, TBI, SCI, Parkinson, pain, and inflammation demonstrated a decrease in microglial activated state18,19,21,22,27,28,30,31. This evidence concerns the gene P2RX7 and epilepsy.